Risk Stratification Of Diffuse Large B-Cell Lymphoma With Interim PET/CT By Combining Deauville Scores And International Prognostic Index

References

• Mamot C, Klingbiel D, Hitz F, et al. Final results of a prospective evaluation of the predictive value of interim positron emission tomography in patients with diffuse large B-cell lymphoma treated with R-CHOP-14 (SAKK 38/07). J Clin Oncol. 2015;33(23):2523–2529. doi:10.1200/JCO.2014.58.984626150440
   PubMed Web of Science ®Google Scholar
• Adams HJ, Kwee TC. Prognostic value of interim FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis. Crit Rev Oncol Hematol. 2016;106:55–63. doi:10.1016/j.critrevonc.2016.07.00327637352
   PubMed Web of Science ®Google Scholar
• Jiang M, Chen P, Ruan X, et al. Interim 18F-FDG PET/CT and BCL2 for predicting the prognosis of patients with diffuse large B-cell lymphoma in the rituximab era. Nucl Med Commun. 2018;39(2):147–153. doi:10.1097/MNM.000000000000078429189488
   PubMed Web of Science ®Google Scholar
• Yuan L, Kreissl MC, Su L, et al. Prognostic analysis of interim 18 F-FDG PET/CT in patients with diffuse large B cell lymphoma after one cycle versus two cycles of chemotherapy. Eur J Nucl Med Mol Imaging. 2019;46(2):478–488. doi:10.1007/s00259-018-4198-630382301
   PubMed Web of Science ®Google Scholar
• Oñate-Ocaña LF, Cortés V, Castillo-Llanos R, et al. Metabolic tumor volume changes assessed by interval 18fluorodeoxyglucose positron emission tomography-computed tomography for the prediction of complete response and survival in patients with diffuse large B-cell lymphoma. Oncol Lett. 2018;16(2):1411–1418. doi:10.3892/ol.2018.881730008818
   PubMed Web of Science ®Google Scholar
• Burggraaff CN, de Jong A, Hoekstra OS, et al. Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2019;46(1):65–79. doi:10.1007/s00259-018-4103-330141066
   PubMed Web of Science ®Google Scholar
• Meignan M, Gallamini A, Haioun C. Report on the First International Workshop on Interim-PET-scan in lymphoma. Leuk Lymphoma. 2009;50(8):1257–1260. doi:10.1080/1042819090304004819544140
   PubMed Web of Science ®Google Scholar
• Kim J, Song YS, Lee JS, Lee WW, Kim SE. Risk stratification of diffuse large B-cell lymphoma with interim PET-CT based on different cutoff Deauville scores. Leuk Lymphoma. 2018;59(2):340–347. doi:10.1080/10428194.2017.133987728629257
   PubMed Web of Science ®Google Scholar
• Safar V, Dupuis J, Itti E, et al. Interim [18F]fluorodeoxyglucose positron emission tomography scan in diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy plus rituximab. J Clin Oncol. 2012;30(2):184–190. doi:10.1200/JCO.2011.38.264822162590
   PubMed Web of Science ®Google Scholar
• Yang DH, Ahn JS, Byun BH, et al. Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era. Ann Hematol. 2013;92(4):471–479. doi:10.1007/s00277-012-1640-x23238895
   PubMed Web of Science ®Google Scholar
• Yang DH, Min JJ, Song HC, et al. Prognostic significance of interim (1)(8)F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma. Eur J Cancer. 2011;47(9):1312–1318. doi:10.1016/j.ejca.2010.12.02721334197
   PubMed Web of Science ®Google Scholar
• Pregno P, Chiappella A, Bello M, et al. Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP. Blood. 2012;119(9):2066–2073. doi:10.1182/blood-2011-06-35994322234681
   PubMed Web of Science ®Google Scholar
• Chow A, Phillips M, Siew T, et al. Prognostic nomogram for diffuse large B-cell lymphoma incorporating the International Prognostic Index with interim-positron emission tomography findings. Intern Med J. 2013;43(8):932–939. doi:10.1111/imj.1219423692386
   PubMed Web of Science ®Google Scholar
• Nols N, Mounier N, Bouazza S, et al. Quantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphoma. Leuk Lymphoma. 2014;55(4):773–780. doi:10.3109/10428194.2013.83184823927393
   PubMed Web of Science ®Google Scholar
• Zelenetz AD, Gordon LI, Wierda WG, et al. Diffuse large B-cell lymphoma version 1.2016. J National Compr Cancer Network. 2016;14(2):196–231. doi:10.6004/jnccn.2016.0023
   PubMed Web of Science ®Google Scholar
• Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059–3068. doi:10.1200/JCO.2013.54.880025113753
   PubMed Web of Science ®Google Scholar
• Barrington SF, Qian W, Somer EJ, et al. Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging. 2010;37(10):1824–1833. doi:10.1007/s00259-010-1490-520505930
   PubMed Web of Science ®Google Scholar
• Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the imaging subcommittee of international harmonization project in lymphoma. J Clin Oncol. 2007;25(5):571–578. doi:10.1200/JCO.2006.08.230517242397
   PubMed Web of Science ®Google Scholar
• Jiang M, Chen P, Ruan X, et al. Interim 18F‑FDG PET/CT improves the prognostic value of S-IPI, R-IPI and NCCN-IPI in patients with diffuse large B‑cell lymphoma. Oncol Lett. 2017;14(6):6715–6723. doi:10.3892/ol.2017.709329344120
   PubMed Web of Science ®Google Scholar
• Itti E, Meignan M, Berriolo-Riedinger A, et al. An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and DeltaSUVmax. Eur J Nucl Med Mol Imaging. 2013;40(9):1312–1320. doi:10.1007/s00259-013-2435-623649463
   PubMed Web of Science ®Google Scholar
• Zhang Y, Fan Y, Ying Z, et al. Can the SUVmax-liver-based interpretation improve prognostic accuracy of interim and posttreatment 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma? Leuk Lymphoma. 2018;59(3):660–669. doi:10.1080/10428194.2017.135717128771052
   PubMed Web of Science ®Google Scholar
• Carr R, Fanti S, Paez D, et al. Prospective international cohort study demonstrates inability of interim PET to predict treatment failure in diffuse large B-cell lymphoma. J Nucl Med. 2014;55(12):1936–1944. doi:10.2967/jnumed.114.14532625429159
   PubMed Web of Science ®Google Scholar